Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 8.

Okada, H; Weller, M; Huang, R; Finocchiaro, G; Gilbert, M R; Wick, W; Ellingson, B M; Hashimoto, N; Pollack, I F; Brandes, Al A; Franceschi, E; Herold-Mende, C; Nayak, L; Panigrahy, A; Pope, W B; Prins, R; Sampson, J H; Wen, P Y; Reardon, D A (2015). Immunotherapy response assessment in neuro-oncology: a report of the RANO working group. Lancet Oncology, 16(15):e534-e542.

Reuss, D E; Sahm, F; Schrimpf, D; Wiestler, B; Capper, D; Koelsche, C; Schweizer, L; Korshunov, A; Jones, D T W; Hovestadt, V; Mittelbronn, M; Schittenhelm, J; Herold-Mende, C; Unterberg, A; Platten, M; Weller, M; Wick, W; Pfister, S M; von Deimling, A (2015). ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an "integrated" diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma. Acta Neuropathologica, 129(1):133-146.

Wiestler, B; Capper, D; Sill, M; Jones, D T W; Hovestadt, V; Sturm, D; Koelsche, C; Bertoni, A; Schweizer, L; Korshunov, A; Weiß, E K; Schliesser, M G; Radbruch, A; Herold-Mende, C; Roth, P; Unterberg, A; Hartmann, C; Pietsch, T; Reifenberger, G; Lichter, P; Radlwimmer, B; Platten, M; Pfister, S M; von Deimling, A; Weller, M; Wick, W (2014). Integrated DNA methylation and copy-number profiling identify three clinically and biologically relevant groups of anaplastic glioma. Acta Neuropathologica, 128(4):561-571.

Neidert, M C; Schoor, O; Trautwein, C; Trautwein, N; Christ, L; Melms, A; Honegger, J; Rammensee, H G; Herold-Mende, C; Dietrich, P Y; Stevanovic, S (2013). Natural HLA class I ligands from glioblastoma: extending the options for immunotherapy. Journal of Neuro-Oncology, 111(3):285-294.

Koelsche, C; Sahm, F; Capper, D; Reuss, D; Sturm, D; Jones, D T W; Kool, M; Northcott, P A; Wiestler, B; Böhmer, K; Meyer, J; Mawrin, C; Hartmann, C; Mittelbronn, M; Platten, M; Brokinkel, B; Seiz, M; Herold-Mende, C; Unterberg, A; Schittenhelm, J; Weller, M; Pfister, S; Wick, W; Korshunov, A; von Deimling, A (2013). Distribution of TERT promoter mutations in pediatric and adult tumors of the nervous system. Acta Neuropathologica, 126(6):907-915.

Chirasani, S R; Sternjak, A; Wend, P; Momma, S; Campos, B; Herrmann, I M; Graf, D; Mitsiadis, T A; Herold-Mende, C; Besser, D; Synowitz, M; Kettenmann, H; Glass, R (2010). Bone morphogenetic protein-7 release from endogenous neural precursor cells suppresses the tumourigenicity of stem-like glioblastoma cells. Brain: A Journal of Neurology, 133(7):1961-1972.

Hartmann, C; Meyer, J; Balss, J; Capper, D; Mueller, W; Christians, A; Felsberg, J; Wolter, M; Mawrin, C; Wick, W; Weller, M; Herold-Mende, C; Unterberg, A; Jeuken, J W M; Wesseling, P; Reifenberger, G; von Deimling, A (2009). Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas. Acta Neuropathologica, 118(4):469-474.

Strelau, J; Schmeer, C; Peterziel, H; Sackmann, T; Herold-Mende, C; Steinert, H; Weller, M; Unsicker, K (2008). Expression and putative functions of GDF-15, a member of the TGF-β superfamily, in human glioma and glioblastoma cell lines. Cancer Letters, 270(1):30-39.

This list was generated on Thu Nov 23 03:36:59 2017 CET.